Kanbay, Mehmet http://orcid.org/0000-0002-1297-0675
Altıntas, Alara
Yavuz, Furkan
Copur, Sidar
Sanchez-Lozada, Laura G.
Lanaspa, Miguel A.
Johnson, Richard J.
Article History
Accepted: 18 October 2022
First Online: 28 January 2023
Compliance with Ethical Standards
: All figures are drawn by the authors. No need to have any permission from other sources.
: Not applicable.
: Not applicable.
: Richard J. Johnson and Miguel A. Lanaspa have equity with Colorado Research Partners LLC that is developing inhibitors of fructose metabolism. Dr Johnson also has stocks with XORTX Therapeutics and has received honoraria from Horizon Pharma. All other authors declare that they have no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors. Not applicable (as this is review article, no human or animal consent is needed).